Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A wide-market index fund retirement portfolio emphasizes broad market coverage, aiming for steady growth with manageable fees.
28,259 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Jefferies boosts Palo Alto Networks price target to $265 with a Buy rating as AI-driven threats compress attack timel...
Solana is often pitched as a blockchain that outpaces and underprices Ethereum. This article digs into why those adva...
SpaceX just won FAA clearance for a new re-entry capsule, a move that could redefine the economics of space data retu...
Oracle stock dips despite a swelling backlog. This guide explains what backlog means, why the stock reacts, and how i...
Palantir rides a wave of AI-driven demand as shares hover around $113. A fresh forecast calls for meaningful upside o...
Shares have pulled back from recent highs, but Nvidia’s momentum in AI data centers remains strong. Analysts see a fr...
Alphabet defies the AI talent exodus narrative as first-quarter results beat estimates. Investors say can’t stop buyi...
A Google-backed study finds only 40% of U.S. workers casually use AI at work, with just 5% AI fluent. The result: big...
Bloom Energy surges in Q4 2025 on AI-driven data-center demand, delivering record revenue and EBITDA. Plug Power turn...
Bitcoin led a $1.06 billion weekly surge in digital asset inflows as geopolitical tensions intensified, underscoring ...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...